S92 Remote monitoring enabled evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension

Autor: JT Middleton, S Binmafooz, H Zafar, J Patel, D Giri, C Battersby, M Toshner, A Reddy, R Lewis, C Durrington, A Swift, R Condliffe, C Elliot, A Hameed, R Thompson, A Charalampopoulos, DG Kiely, AMK Rothman

Publikováno v: ‘The Sixth Sense’ – Prognostication in pulmonary vascular disease.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70ebfc7bd65bc2cd57b501d752903ded
https://doi.org/10.1136/thorax-2022-btsabstracts.98

Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.

Autor: Varian F; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Dick J; Division of Clinical Medicine University of Sheffield Sheffield UK., Battersby C; Division of Clinical Medicine University of Sheffield Sheffield UK., Roman S; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Ablott J; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Watson L; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Binmahfooz S; Division of Clinical Medicine University of Sheffield Sheffield UK., Zafar H; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Colgan G; Royal Free NHS Foundation Trust London UK., Cannon J; Royal Papworth Hospital NHS Foundation Trust Cambridge UK., Suntharalingam J; Royal United Hospitals Bath NHS Foundation Trust Bath UK., Lordan J; Newcastle Hospitals NHS Foundation Trust Newcastle UK., Howard L; Imperial College Healthcare NHS Trust London UK., McCabe C; Royal Brompton and Harefield Guy's and St Thomas' NHS Foundation Trust London UK., Wort J; NHS Greater Glasgow and Clyde Glasgow UK., Price L; NHS Greater Glasgow and Clyde Glasgow UK., Church C; National Heart and Lung Institute, Faculty of Medicine, Imperial College London London UK., Hamilton N; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Armstrong I; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Hameed A; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Hurdman J; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Elliot C; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Wilkins M; National Heart and Lung Institute, Faculty of Medicine, Imperial College London London UK., Webb A; Wolfson Centre for Prevention of Stroke and Dementia University of Oxford Oxford UK., Adlam D; Cardiovascular Research Unit of Leicester Leicester UK., Benza RL; Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York New York USA., Rahimi K; Deep Medicine, Nuffield Department of Women's and Reproductive Health University of Oxford Oxford UK., Shojaei-Shahrokhabadi M; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK., Lin NX; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK., Wason JMS; Biostatistics Research Group, Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK., McIntosh A; Robertson Centre for Biostatistics, School of Health and Wellbeing University of Glasgow Glasgow UK., McConnachie A; Robertson Centre for Biostatistics, School of Health and Wellbeing University of Glasgow Glasgow UK., Middleton JT; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Thompson R; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Kiely DG; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK., Toshner M; Department of Medicine, Heart and Lung Research Institute University of Cambridge Cambridge UK., Rothman A; Division of Clinical Medicine University of Sheffield Sheffield UK.; Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.

Publikováno v: Pulmonary circulation [Pulm Circ] 2024 Mar 17; Vol. 14 (1), pp. e12337. Date of Electronic Publication: 2024 Mar 17 (Print Publication: 2024).

Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approaches.

Autor: Sammut MA; Department of Cardiology, Northern General Hospital, Sheffield, UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Hameed A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Lewis R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Kyriacou A; Department of Cardiology, Northern General Hospital, Sheffield, UK., Middleton JT; Department of Cardiology, Northern General Hospital, Sheffield, UK; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Raithatha A; Department of Critical Care, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Rothman A; Department of Cardiology, Northern General Hospital, Sheffield, UK; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Turner R; Department of Respiratory Medicine, Imperial College Healthcare Trust, London, UK., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. Electronic address: athanasios.charalampopoulos@nhs.net.

Publikováno v: International journal of cardiology [Int J Cardiol] 2023 Jan 15; Vol. 371, pp. 363-370. Date of Electronic Publication: 2022 Sep 18.

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension.

Autor: Middleton JT; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom.; Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Maulik A; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom.; Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Lewis R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Toshner M; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.; Royal Papworth Hospital NHS Foundation Trust, Cambridgeshire, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Kyriacou A; Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Rothman A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom.; Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2019 Jul 23; Vol. 6, pp. 169. Date of Electronic Publication: 2019 Jul 23 (Print Publication: 2019).

The occurrence, distribution, and significance of photochemical air pollution in the United States, Canada, and Mexico.

Autor: MIDDLETON JT, HAAGEN-SMIT AJ

Publikováno v: Journal of the Air Pollution Control Association [J Air Pollut Control Assoc] 1961 Mar; Vol. 11, pp. 129-34.